Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin

BACKGROUND: The efficacy of flibanserin in treating hypoactive sexual desire disorder (HSDD) is based upon statistically significant improvements in sexual desire, satisfying sexual events, and distress. However, clinically meaningful benefit has not been well characterized. AIM: Evaluate clinically...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, James A., Clayton, Anita H., Kim, Noel N., Patel, Sejal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847820/
https://www.ncbi.nlm.nih.gov/pubmed/34999484
http://dx.doi.org/10.1016/j.esxm.2021.100476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847820/
https://www.ncbi.nlm.nih.gov/pubmed/34999484
http://dx.doi.org/10.1016/j.esxm.2021.100476

Ejemplares similares